Molecular Neurobiology, 2020 · DOI: https://doi.org/10.1007/s12035-019-01731-5 · Published: August 30, 2019
PPARGC1A encodes PGC-1α, a transcriptional co-activator involved in multiple transcriptional programs, including those relevant to neurodegenerative diseases. The study identifies CNS-specific transcripts of PPARGC1A and examines how their expression is regulated in neuronal cells. A variable GT repeat polymorphism in the CNS promoter region influences promoter activity, and hypoxia also regulates CNS-specific transcript expression.
The GT repeat polymorphism may explain inter-individual variability in CNS transcript expression and response to hypoxia.
Understanding the regulation of CNS-specific PPARGC1A transcripts could lead to new therapeutic targets for neurodegenerative diseases and ischemia.
FOXA2's role in activating the CNS-specific promoter suggests a link to the development and maintenance of dopaminergic mid-brain neurons.